19
Allegato B

Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 2: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 3: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 4: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 5: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 6: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 7: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 8: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 9: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 10: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 11: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 12: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 13: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 14: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 15: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 16: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 17: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 18: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B

Page 19: Allegato B - ARERA · Article 3(e) of CACM Regulation aims at ensuring fair and non-discriminatory treatment of T SOS, NEMOs, the Agency, regulatory authorities and market participants

Allegato B